What's new
Minichiello group discovers a novel stem cell population in the subventricular zone
17 July 2026
A new study by the Minichiello group, published in Cell Discovery, has identified a previously unappreciated population of deeply quiescent neural stem cells in the largest germinal zone in the adult mammalian brain, lining the walls of the lateral ventricles, so-called the ventricular-subventricular zone (V-SVZ).
New study reveals specialised subpopulations of head direction cells in the mouse thalamus
10 June 2026
Researchers from the Viney Group in the Department of Pharmacology, along with collaborators from The Center for Systems Neuroscience, Boston University, US, have identified distinct subpopulations of head direction (HD) cells in the mouse thalamus, revealing that the brain's internal compass is composed of specialised neurons that differ in their sensorimotor responses, molecular identity, and connectivity.
Lanyon-Hogg group publishes new approach to antibiotic resistance
26 May 2026
A new paper, published in Cell Chemical Biology, highlights a new protein in methicillin-resistant Staphylococcus aureus (MRSA) that could be a potential new target for antibiotic drug discovery. The research, carried out in the Lanyon-Hogg group in Pharmacology, in collaboration with the Ineos Oxford Institute for antimicrobial research, shows that molecules targeting this protein, called SpsB, can slow the rate at which MRSA develops resistance to antibiotics such as ciprofloxacin.
Oxford-led study reveals new way to activate protein kinases, opening new therapeutic possibilities
10 April 2026
Researchers at the University of Oxford have developed a new strategy to activate protein kinases — a major class of enzymes that regulate essential cellular processes — offering a potential pathway to treat diseases where current therapies remain limited.
